Multiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice

dc.contributor.authorAltés, Gisela
dc.contributor.authorOlomí, Anna
dc.contributor.authorPerramon Güell, Aida
dc.contributor.authorHernández, Sara
dc.contributor.authorCasanovas, Anna
dc.contributor.authorPérez, Aurora
dc.contributor.authorDíaz Tocados, Juan Miguel
dc.contributor.authorValdivielso, José Manuel
dc.contributor.authorMegino, Cristina
dc.contributor.authorNavaridas, Raúl
dc.contributor.authorMatias-Guiu, Xavier, 1958-
dc.contributor.authorKlein, Ophir D.
dc.contributor.authorEgea, Joaquim
dc.contributor.authorDolcet, Xavi
dc.contributor.authorYeramian, Andrée
dc.contributor.authorEncinas, Mario
dc.date.accessioned2024-11-11T14:32:07Z
dc.date.available2024-11-11T14:32:07Z
dc.date.issued2024-08-22
dc.date.updated2024-10-04T11:06:05Z
dc.description.abstractGenes of the Sprouty family (Spry1-4) are feedback inhibitors of receptor tyrosine kinases, especially of Ret and the FGF receptors. As such, they play distinct and overlapping roles in embryo morphogenesis and are considered to be tumor suppressors in adult life. Genetic experiments in mice have defined in great detail the role of these genes during embryonic development, however their function in adult mice is less clearly established. Here we generate adult-onset, whole body Spry1/2/4 triple knockout mice. Tumor incidence in triple mutant mice is comparable to that of wild type littermates of up to one year of age, indicating that Sprouty loss per se is not sufficient to initiate tumorigenesis. On the other hand, triple knockout mice do not gain weight as they age, show less visceral fat, and have lower plasma glucose levels than wild type littermates, despite showing similar food intake and slightly reduced motor function. They also show alopecia, eyelid inflammation, and mild hyperthyroidism. Finally, triple knockout mice present phosphaturia and hypophosphatemia, suggesting exacerbated signaling downstream of FGF23. In conclusion, triple knockout mice develop a series of endocrine abnormalities but do not show increased tumor incidence.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.issn2045-2322
dc.identifier.pmid39174793
dc.identifier.urihttps://hdl.handle.net/2445/216348
dc.language.isoeng
dc.publisherSpringer Science and Business Media LLC
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1038/s41598-024-70529-w
dc.relation.ispartofScientific Reports, 2024, vol. 14, num. 1
dc.relation.urihttps://doi.org/10.1038/s41598-024-70529-w
dc.rightscc by-nc-nd (c) Altés, Gisela et al., 2024
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/es/*
dc.sourceArticles publicats en revistes (Institut d'lnvestigació Biomèdica de Bellvitge (IDIBELL))
dc.subject.classificationExperimentació animal
dc.subject.classificationEndocrinologia
dc.subject.otherAnimal experimentation
dc.subject.otherEndocrinology
dc.titleMultiple endocrine defects in adult-onset Sprouty1/2/4 triple knockout mice
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
s41598-024-70529-w.pdf
Mida:
2.89 MB
Format:
Adobe Portable Document Format